Exhibitor Spotlight Theaters
Please Note: These Exhibitor Spotlight Theaters are promotional activities and are not approved for continuing education credit. The content of these Exhibitor Spotlight Theaters and opinions expressed by presenters are those of the sponsor or presenter and are not of the American Association for Cancer Research (AACR®).
All Spotlight Theaters are located in the South Hall A.
Browse Schedules by Category:
Redefining What’s Possible in Cancer Research with Revolutionarily, Simple, and Cost-effective Single Cell, Spatial, and Multiomic Approaches
Theater A
Presented by Illumina, Inc.
Innovative Solutions to Power Strategic Insights: Bridging Discovery to Clinical Development
Theater B
Presented by LabCorp.
Using 6-base Genomic Data to Study Cancer Therapy Resistance, Identify Early Classifiers, and Uncover Epigenetic Mechanisms Controlling DNA Replication
Theater D
Presented by biomodal.
Revolutionizing Multiomic Profiling: Tagomics’ Interlace Platform and Agilent’s SureSelect Cancer PanHeme Assay
Theater E
Presented by Agilent Technologies.
High Throughput Single Cell Genomics Enables the Mechanistic Characterization of Blood Cancers
Theater C
Presented by Scale Biosciences.
From Complexity to Clarity: Workflow Automation for Spatial Biology at Scale
Theater A
Presented by ZEISS Microscopy.
Redefining Multi-Omics with Codetta Bio: Quantifying Proteins and Nucleic Acids from the Same Sample in One Seamless Workflow
Theater B
Presented by Codetta Bio.
Introducing Beacon Discovery: Bringing Live Single-Cell Multi-Parameter Functional Analysis to Every Lab
Theater C
Presented by Bruker Cellular Analysis.
Harnessing Spatial Multiomic Biomarkers: Ushering in a New Era of Precision Oncology
Theater D
Presented by PredxBio.
Unraveling Tumor Complexity with SignalStar® Multiplex IHC and InTraSeq™ Single Cell Analysis: Antibody-Based Approaches in Spatial Biology and scRNA-seq
Theater E
Presented by Cell Signaling Technology.
Maximizing The Potential of Liquid Biopsy – From Multianalyte Analysis to Comprehensive Genomic Profiling
Theater A
Presented by QIAGEN.
Transforming R&D with Generative AI and Real-World Data
Theater B
Presented by Tempus.
Whole Genome Sequencing Using SBX Technology
Theater C
Presented by Roche Sequencing & Life Sciences.
Sequencing the Immune Trajectory from Early Diagnosis to Resistance in Multiple Myeloma
Theater D
Presented by BD Biosciences.
Enhancing Cancer Therapy Precision: Patient Derived Organoids to Interrogate Phenotypic Transitions in Metastatic Cancer and for High-Throughput Therapeutic Screening
Theater E
Presented by Corning Life Sciences.
Developing Multi-Modal MRD and ctDNA Tests for Use in Clinical Research: Droplet Digital PCR-Driven Mutation and Methylation Quantification, CTCs and Proteomics
Theater A
Presented by Bio-Rad Laboratories.
A New Day in Cancer Variant Discovery with Accurate Long-Read Sequencing
Theater B
Presented by PacBio.
Unlock Transformative Cancer Insights: The Power of Ultra-Rich Nanopore Sequencing
Theater C
Presented by Oxford Nanopore Technologies.
Lost in Omics? Navigating the Path from Protein Discovery to Healthcare Impacts
Theater D
Presented by Standard BioTools.
Innovative Approaches in 3D Whole Slide Cancer Imaging
Theater E
Presented by 3DHISTECH.
Scaling Immuno-Oncology Research with IO60: The Fastest Ultra High-Plex Spatial Proteomics Panel
Theater A
Presented by Akoya Biosciences Inc.
On Target: HER2 Therapies Shaping the Future of Cancer Treatment
Theater B
Presented by Charles River.
Shifting the Paradigm in Cancer Screening: The Promise, Potential, and Pressing Questions of Multi-Cancer Early Detection (MCED) Testing
Theater C
Presented by Exact Sciences.
CRISPR Screens, TCR & BCR Sequencing and Other Approaches for Drug Target and Biomarker Discovery
Theater D
Presented by Cellecta, Inc.
Transformative Proteomics: Leveraging Affinity Based Assays to Advance Immunotherapy and Precision Prevention in Cancer Research
Theater E
Presented by Olink Proteomics Inc.
Protein Quantitation for Characterization of Potential Cancer Therapeutics in Early Discovery and Mechanism of Action Insights in Translational Studies
Theater A
Presented by Bio-Techne.
Human Hematopoietic Stem Cell and Peripheral Blood Mononuclear Cell Platforms for In Vivo Immune Modulatory Drug Discovery
Theater B
Presented by The Jackson Laboratory.
Spatial Proteomics of Cell States and Extracellular Matrix in Glioma and Carcinoma
Theater C
Presented by Abcam.
Harnessing Spatial Biology and Agentic AI to Optimize ADC Clinical Development Strategies
Theater D
Presented by Owkin.
Strategies for Improved Engraftment and Data Reproducibility in Humanized Immune System (HIS) Mice
Theater E
Presented by Taconic Biosciences.
From Neurogenesis to Brain Cancer: Imaging Glioblastoma Development in Mice
Theater A
Presented by Miltenyi Biotec B.V. & Co. KG.
Computational Pathology: Transforming Patient Selection and Therapeutic Response Prediction in Drug Development
Theater B
Presented by AstraZeneca.
High-Throughput Serum Proteomics of 1000+ Checkpoint Inhibitor Patients: Insights From nELISA™ Profiling of RADIOHEAD Cohort
Theater C
Presented by Nomic Bio.
Advanced Reference Materials Supporting NGS Validation of Complex Cancer Variants
Theater D
Presented by LGC Clinical Diagnostics.
Transforming Oncology: ATCC’s Cutting-Edge Patient-Derived Models
Theater E
Presented by ATCC.
Identification of Novel Blood-based Signatures of Disease and Therapeutic Response Using High-sensitivity NULISA Protein Assays
Theater A
Presented by Alamar Biosciences.
Advancing Oncology Research and Minimal Residual Disease Detection with Inocra’s Whole Genome Cancer Platform
Theater B
Presented by Inocras.
Expanding the Limits of Biology: Comprehensive Integrated Technologies for Multiomics in Oncology
Theater C
Presented by Bruker Spatial Biology.
Tumor Evolution and Microenvironment Interactions in Spatial Dimensions
Theater D
Presented by 10x Genomics.
Assessment of Translational Tumor Biology, and Biologic’s Efficacy and Safety in Preclinical Humanized Models
Theater E
Presented by genOway.